Cargando…

CRIMALDDI: a prioritized research agenda to expedite the discovery of new anti-malarial drugs

The CRIMALDDI Consortium has been a three-year project funded by the EU Framework Seven Programme. It aimed to develop a prioritized set of recommendations to speed up anti-malarial drug discovery research and contribute to the setting of the global research agenda. It has attempted to align thinkin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ward, Steve A, Boulton, Ian C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830512/ https://www.ncbi.nlm.nih.gov/pubmed/24191947 http://dx.doi.org/10.1186/1475-2875-12-395

Ejemplares similares

CRIMALDDI: platform technologies and novel anti-malarial drug targets
por: Vial, Henri, et al.
Publicado: (2013)

CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives
por: Boulton, Ian C, et al.
Publicado: (2010)

An in vitro toolbox to accelerate anti-malarial drug discovery and development
por: Charman, Susan A., et al.
Publicado: (2020)

Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs
por: Egieyeh, Samuel Ayodele, et al.
Publicado: (2016)

Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate
por: Matthews, Holly, et al.
Publicado: (2013)

Intense bitterness of molecules: Machine learning for expediting drug discovery
por: Margulis, Eitan, et al.
Publicado: (2020)

Attention expedites target selection by prioritizing the neural processing of distractor features
por: Bartsch, Mandy V., et al.
Publicado: (2021)

Scaling Up Programmatic Management of Drug-Resistant Tuberculosis: A Prioritized Research Agenda
por: Cobelens, Frank G. J, et al.
Publicado: (2008)

The Future of Anti-Malarial Research
por: Senior-White, Ronald, et al.
Publicado: (1927)

Prioritization of Molecular Targets for Antimalarial Drug Discovery
por: Forte, Barbara, et al.
Publicado: (2021)

Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs
por: Tougan, Takahiro, et al.
Publicado: (2019)

Measuring windows of selection for anti-malarial drug treatments
por: Kay, Katherine, et al.
Publicado: (2015)

Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties
por: Chumanevich, Alexander A., et al.
Publicado: (2016)

Novel Highlight in Malarial Drug Discovery: Aspartate Transcarbamoylase
por: Wang, Chao, et al.
Publicado: (2022)

A new anti-malarial drug against murine malaria
por: Zamani, Zahra, et al.
Publicado: (2011)

Anti-malarial Drug Design by Targeting Apicoplasts: New Perspectives
por: Mukherjee, Avinaba, et al.
Publicado: (2016)

Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria
por: Macintyre, Fiona, et al.
Publicado: (2018)

A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents
por: Bahamontes-Rosa, Noemí, et al.
Publicado: (2016)

Artemisinin anti-malarial drugs in China
por: Guo, Zongru
Publicado: (2016)

Few new drugs deserve expedited regulatory treatment
por: Darrow, Jonathan J
Publicado: (2021)

The New Arctic Expedition
Publicado: (1860)

Quantum dots: a new tool for anti-malarial drug assays
por: Ku, Min-Je, et al.
Publicado: (2011)

Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
por: Navarro, Maribel, et al.
Publicado: (2014)

Substandard anti-malarial drugs in Burkina Faso
por: Tipke, Maike, et al.
Publicado: (2008)

The role of anti-malarial drugs in eliminating malaria
por: White, Nicholas J
Publicado: (2008)

Spectrophotometric detection of susceptibility to anti-malarial drugs
por: Serebrennikova, Yulia M, et al.
Publicado: (2013)

Note on Economy in the Use of Anti-Malarial Drugs
por: Covell, G.
Publicado: (1942)

A research agenda to reinforce rabies control: A qualitative and quantitative prioritization
por: Neevel, Anne M. G., et al.
Publicado: (2018)

Prioritizing a Research Agenda of Transitional Care Interventions for Childhood-Onset Disabilities
por: Duncan, Andrea, et al.
Publicado: (2021)

A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria
por: Mokuolu, Olugbenga Ayodeji, et al.
Publicado: (2023)

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
por: Monatrakul, Preeyaporn, et al.
Publicado: (2010)

Expedition: Cosmic research poles apart
por: Chalmers, Matthew, et al.
Publicado: (2018)

Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
por: Tam, Dao Ngoc Hien, et al.
Publicado: (2020)

Patient-driven initiatives for prioritizing drug discovery for rare diseases
por: Bhattacharya, Alok, et al.
Publicado: (2019)

Informing the research agenda for optimizing audit and feedback interventions: results of a prioritization exercise
por: Colquhoun, Heather L., et al.
Publicado: (2021)

Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
por: Pongtavornpinyo, Wirichada, et al.
Publicado: (2008)

In vitro and in vivo combination of cepharanthine with anti-malarial drugs
por: Desgrouas, Camille, et al.
Publicado: (2014)

Anti-malarial effect of semi-synthetic drug amitozyn
por: Tcherniuk, Sergey O., et al.
Publicado: (2015)

Present Position of Anti-Malarial Drug Therapy in India
por: Chopra, R. N.
Publicado: (1938)

Anti‐malarial drugs: Mechanisms underlying their proarrhythmic effects
por: Saadeh, Khalil, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1aneq7orsm8uklpm73169ksc3m